166 related articles for article (PubMed ID: 6252803)
21. Cast nephropathy in mu heavy chain disease.
Preud'homme JL; Bauwens M; Dumont G; Goujon JM; Dreyfus B; Touchard G
Clin Nephrol; 1997 Aug; 48(2):118-21. PubMed ID: 9285150
[TBL] [Abstract][Full Text] [Related]
22. [Gamma-heavy chain disease associated with MALT lymphoma of the duodenum].
Ieko M; Kohno M; Ohmoto A; Notoya A; Fukazawa Y; Yasukouchi T; Sawada K; Koike T
Rinsho Ketsueki; 1998 Jul; 39(7):512-8. PubMed ID: 9750459
[TBL] [Abstract][Full Text] [Related]
23. Deleted IgG1 and IgG2 H chains in a patient with an IgG subclass imbalance.
Lebreton JP; Fontaine M; Rousseaux J; Youinou P; Hurez D; Rivat-Peran L; Bernards JP
Clin Exp Immunol; 1982 Jan; 47(1):206-16. PubMed ID: 6807588
[TBL] [Abstract][Full Text] [Related]
24. Gamma heavy chain disease DUB: clinical, immunochemical and pathological studies.
Roda L; David MJ; Biron P; Souche S; Creyssel R
Haematologica; 1985; 70(3):232-5. PubMed ID: 3932151
[No Abstract] [Full Text] [Related]
25. Gamma heavy chain disease in a patient with underlying lymphoplasmacytic lymphoma of the thyroid. Report of a case and comparison with other reported cases with thyroid involvement.
Tan JN; Kroll MH; O'Hara CJ; Everett PC; Erdogan E
Clin Chim Acta; 2012 Oct; 413(19-20):1696-9. PubMed ID: 22561184
[TBL] [Abstract][Full Text] [Related]
26. Rapid evolution in the immunochemical findings of a gamma heavy chain disease.
Pontet F; Gué X; Dosquet C; Caen J; Rousselet F
Clin Chem; 1988 Feb; 34(2):439-43. PubMed ID: 3124986
[TBL] [Abstract][Full Text] [Related]
27. [Gamma heavy chain disease. A new case].
Loyau G; Barré JP; L'Hirondel JL; Maniéce M; Preud'Homme JL
Nouv Presse Med; 1975 Mar; 4(13):957-9. PubMed ID: 806896
[TBL] [Abstract][Full Text] [Related]
28. Gamma heavy chain disease in a patient with diabetes and chronic renal insufficiency: diagnostic assessment of the heavy chain fragment.
Lee MT; Parwani A; Humphrey R; Hamilton RG; Myers DI; Detrick B
J Clin Lab Anal; 2008; 22(2):146-50. PubMed ID: 18348312
[TBL] [Abstract][Full Text] [Related]
29. [Development of gamma-heavy chain disease during the course of diabetic nephropathy].
Ohtani S; Mashiko T; Kanoh Y; Shimetani N; Ohtani H
Rinsho Ketsueki; 2000 Mar; 41(3):192-7. PubMed ID: 10774247
[TBL] [Abstract][Full Text] [Related]
30. Gamma heavy chain disease screening showing a discrepancy between electrophoretic and nephelometric determinations of serum gamma globulin concentration.
Takatani T; Morita K; Takaoka N; Tatsumi M; Okuno Y; Masutani T; Murakawa K; Fukui A; Tsukaguchi N; Okamoto Y
Ann Clin Biochem; 2002 Sep; 39(Pt 5):531-3. PubMed ID: 12227865
[TBL] [Abstract][Full Text] [Related]
31. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis.
Yasuda T; Fujita K; Imai H; Morita K; Nakamoto Y; Miura AB
Clin Nephrol; 1995 Dec; 44(6):394-9. PubMed ID: 8719552
[TBL] [Abstract][Full Text] [Related]
32. [Heavy gamma-chain diseases. A new case and review of the literature].
Leloup E; Gallinari C; Bouchon JP; Benis Y
Ann Med Interne (Paris); 1989; 140(4):274-8. PubMed ID: 2506787
[TBL] [Abstract][Full Text] [Related]
33. [Alpha chain disease. Report of a case (author's transl)].
Philippe N; Monnet P
Sem Hop; 1978 Nov 18-25; 54(41-42):1276-7. PubMed ID: 216108
[TBL] [Abstract][Full Text] [Related]
34. Tubulointerstitial nephritis accompanying gamma-heavy chain deposition and gamma-heavy chain restricted plasma cells in the kidney.
Nayer A; Green DF; Gonzalez-Suarez ML; Sujoy V; Ikpatt OF; Thomas DB
Iran J Kidney Dis; 2014 Sep; 8(5):417-23. PubMed ID: 25194410
[TBL] [Abstract][Full Text] [Related]
35. [Gamma 1 heavy chain disease with immune vasculitis and rheumatoid arthritis].
Stühlinger W; Berek K; Lapin A; Jaschke E; Pastner D
Klin Wochenschr; 1987 Apr; 65(8):359-68. PubMed ID: 3108571
[TBL] [Abstract][Full Text] [Related]
36. [Heavy chain deposition disease: report of a case and review of the literature].
Imai H
Rinsho Byori; 2001 Jul; 49(7):695-8. PubMed ID: 11519134
[TBL] [Abstract][Full Text] [Related]
37. A comparison of several immunochemical approaches for the screening of alpha chain disease.
Orr KB
Diagn Immunol; 1983; 1(1):43-8. PubMed ID: 6437724
[TBL] [Abstract][Full Text] [Related]
38. A case of gamma-heavy chain monoclonal gammopathy of undetermined significance.
Lenders JW; Holdrinet RS; Nguyen CT; De Waal R
Neth J Med; 1984; 27(10):412-6. PubMed ID: 6440038
[No Abstract] [Full Text] [Related]
39. [Heavy chain disease gamma I Har: molecular defect (author's transl)].
Garcia Pardo A; Maddison SE; Frangione B
Sangre (Barc); 1978; 23(1):31-8. PubMed ID: 635729
[No Abstract] [Full Text] [Related]
40. Unusual gamma heavy chain disease protein in a patient with splenic marginal-zone lymphoma.
Morita K; Kawamoto H; Takada H; Nakamura S; Ishii K; Okamoto Y
Ann Clin Biochem; 2006 Mar; 43(Pt 2):161-4. PubMed ID: 16536920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
